1. Home
  2. SSTK vs COLL Comparison

SSTK vs COLL Comparison

Compare SSTK & COLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Shutterstock Inc.

SSTK

Shutterstock Inc.

HOLD

Current Price

$18.44

Market Cap

675.2M

Sector

Technology

ML Signal

HOLD

Logo Collegium Pharmaceutical Inc.

COLL

Collegium Pharmaceutical Inc.

HOLD

Current Price

$49.78

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SSTK
COLL
Founded
2003
2002
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
675.2M
1.5B
IPO Year
2012
2015

Fundamental Metrics

Financial Performance
Metric
SSTK
COLL
Price
$18.44
$49.78
Analyst Decision
Buy
Strong Buy
Analyst Count
2
6
Target Price
$25.00
$47.50
AVG Volume (30 Days)
279.2K
488.1K
Earning Date
11-05-2025
11-06-2025
Dividend Yield
7.22%
N/A
EPS Growth
66.87
N/A
EPS
1.69
1.63
Revenue
$1,020,010,000.00
$757,067,000.00
Revenue This Year
$11.41
$26.35
Revenue Next Year
N/A
$3.67
P/E Ratio
$10.84
$30.66
Revenue Growth
13.06
26.34
52 Week Low
$14.35
$23.23
52 Week High
$38.80
$50.01

Technical Indicators

Market Signals
Indicator
SSTK
COLL
Relative Strength Index (RSI) 40.19 70.68
Support Level $18.22 $48.50
Resistance Level $19.16 $49.92
Average True Range (ATR) 0.68 1.30
MACD 0.06 -0.22
Stochastic Oscillator 25.51 93.78

Price Performance

Historical Comparison
SSTK
COLL

About SSTK Shutterstock Inc.

Shutterstock Inc is a U.S.-based company that is engaged in the provision of digital content. The content segment, whose offerings include licenses for Images, Footage, Music, 3 Dimensional, and Generative AI content. Data, Distribution, and Service offerings address customer demand for products and services that are beyond its Content licenses. The company generates the majority of its revenue from Content offerings. Geographically the company generates the majority of its revenue from the Domestic market, but also has its presence in Europe and Rest of the Countries.

About COLL Collegium Pharmaceutical Inc.

Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.

Share on Social Networks: